Lulyera Cream contains Luliconazole 1% w/w, a topical antifungal agent belonging to the imidazole class, indicated for the treatment of superficial fungal infections of the skin. Luliconazole exhibits broad-spectrum antifungal activity against dermatophytes, yeasts, and molds by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Lulyera Cream is primarily prescribed for conditions such as tinea corporis, tinea cruris, and tinea pedis. The formulation is applied once daily to the affected area and surrounding skin after cleansing and drying, typically for a duration of 2 to 4 weeks depending on the severity and site of infection. It is well tolerated, with minimal systemic absorption, reducing the risk of systemic side effects. Common adverse reactions may include mild local irritation, burning sensation, or erythema at the application site, which are generally transient. Lulyera Cream should be used with caution in patients with known hypersensitivity to luliconazole or any of the cream’s excipients. It is contraindicated in cases of fungal infections involving mucous membranes or nails. Proper adherence to the prescribed regimen is essential to ensure complete resolution of infection and to prevent recurrence.